Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
3 hedge funds and large institutions have $294K invested in Syra Health Corp. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$289K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$4.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.19K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Walleye Capital
New York
| $289K | +$289K | +96,345 | New |
|
|
FIA
2
FNY Investment Advisers
New York
| $4K | +$4.5K | +1,500 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1.19K | +$1.19K | +396 | New |
|
SYRA Hedge Fund Activity: Q3 2023 in Review
3 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q3 2023, worth a combined $294K.
Buyers outnumbered sellers: 3 funds opened new SYRA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $289K.
- 3 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $294K of Syra Health Corp. Class A Common Stock stock for Q3 2023.
- 3 funds opened new Syra Health Corp. Class A Common Stock positions in Q3 2023 and 0 closed out, a net change of +3 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q3 2023 was Walleye Capital, an estimated $289K added.
Based on aggregated 13F filings for Q3 2023.